InvestorsHub Logo
Followers 24
Posts 2195
Boards Moderated 0
Alias Born 04/26/2012

Re: None

Saturday, 04/13/2019 11:58:33 PM

Saturday, April 13, 2019 11:58:33 PM

Post# of 2338751
$PULM

Pulmazole deal. PULM will receive $22M upfront and will retain the right to receive 50% of the free cash flow from future Pulmazole sales. PULM will be primarily responsible for clinical development while Cipla will be responsible for commercialization.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.